Discover 658 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 658
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
for
Non-Nutritive Sweetener, Type 1 Diabetes, type1diabetes,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 15 - 24
Code: NCT07434544
Recruiting
New
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
for
Richter Syndrome,
Location: Milwaukee WI, Oak Creek WI, New Berlin WI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07220187
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
for
Recurrent Soft Tissue Sarcoma of the Trunk and Extremities,
Location: Milwaukee WI, Oak Creek WI, New Berlin WI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07615049
Phase 3, Recruiting
Striated Esophageal Motor Function Modulation in Health and Disease
for
Dysphagia, Esophageal
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18 - 70+
Code: NCT05708885
Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
for
Parkinson's Disease
Location: Milwaukee WI, Evanston IL, Chicago IL, Iowa City IA,
Sponsor: Parkinson's Foundation
Sex: All
Age: 18+
Code: NCT04994015
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Rochester MN,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT04774159
Phase 3, Recruiting
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
for
Multiple Sclerosis, Relapsing-Remitting
Location: Milwaukee WI, Chicago IL, Louisville KY, Tampa FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 10 - 17
Code: NCT06408259
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Milwaukee WI, Chicago IL, Buffalo NY, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase 1, Phase 2, Recruiting
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC